Compare DKS Co., Ltd. with Similar Stocks
Dashboard
1
With a growth in Net Profit of 70.98%, the company declared Outstanding results in Dec 25
- The company has declared positive results for the last 6 consecutive quarters
- ROCE(HY) Highest at 11.24%
- DEBT-EQUITY RATIO (HY) Lowest at 16.84 %
- INTEREST COVERAGE RATIO(Q) Highest at 5,595.77
2
With ROCE of 15.27%, it has a attractive valuation with a 1.79 Enterprise value to Capital Employed
3
Market Beating Performance
Stock DNA
Specialty Chemicals
JPY 95,625 Million (Small Cap)
15.00
NA
0.00%
0.16
12.87%
1.97
Revenue and Profits:
Net Sales:
22,598 Million
(Quarterly Results - Dec 2025)
Net Profit:
2,412 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.45%
0%
-18.45%
6 Months
26.49%
0%
26.49%
1 Year
247.47%
0%
247.47%
2 Years
169.38%
0%
169.38%
3 Years
366.32%
0%
366.32%
4 Years
243.99%
0%
243.99%
5 Years
138.45%
0%
138.45%
DKS Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.18%
EBIT Growth (5y)
14.90%
EBIT to Interest (avg)
14.40
Debt to EBITDA (avg)
2.72
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
1.00
Tax Ratio
26.43%
Dividend Payout Ratio
37.04%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
6.73%
ROE (avg)
7.07%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.91
EV to EBIT
11.70
EV to EBITDA
8.56
EV to Capital Employed
1.79
EV to Sales
1.27
PEG Ratio
0.25
Dividend Yield
NA
ROCE (Latest)
15.27%
ROE (Latest)
12.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Dec 2011
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
22,598.00
18,565.00
21.72%
Operating Profit (PBDIT) excl Other Income
3,973.00
2,919.00
36.11%
Interest
71.00
72.00
-1.39%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,412.00
1,333.00
80.95%
Operating Profit Margin (Excl OI)
141.20%
115.50%
2.57%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 21.72% vs -2.53% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 80.95% vs 9.26% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
73,255.00
63,118.00
16.06%
Operating Profit (PBDIT) excl Other Income
8,575.00
5,294.00
61.98%
Interest
260.00
295.00
-11.86%
Exceptional Items
-365.00
-66.00
-453.03%
Consolidate Net Profit
3,820.00
1,642.00
132.64%
Operating Profit Margin (Excl OI)
73.10%
32.90%
4.02%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 16.06% vs -3.02% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 132.64% vs 3,451.02% in Mar 2024
About DKS Co., Ltd. 
DKS Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






